Related Experiment Video
Updated: Jul 4, 2025
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
94.4K
Hyperglycemic Stress Induces Expression, Degradation, and Nuclear Association of Rho GDP Dissociation Inhibitor 2
Noah Gleason1,2, Anjaneyulu Kowluru1,2
1Research Service, John D. Dingell VA Medical Center, Detroit, MI 48201, USA.
Cells
|February 9, 2024
Summary
Chronic hyperglycemia increases RhoGDIβ expression and nuclear translocation in beta cells, contributing to cell dysfunction via the RhoGDIβ-Rac1 pathway.
Area of Science:
- Cell Biology
- Endocrinology
- Metabolic Research
Background:
- Small G proteins, like Rac1, are crucial for islet beta-cell function and survival.
- GDP dissociation inhibitors (GDIs) regulate G protein activity.
- Metabolic stress, such as hyperglycemia, impairs beta-cell function.
Purpose of the Study:
- To investigate the impact of chronic hyperglycemic stress on RhoGDI isoforms (RhoGDIα, RhoGDIβ, RhoGDIγ) in beta cells.
- To determine how hyperglycemia affects the expression and subcellular localization of RhoGDIs.
Main Methods:
- Utilized INS-1 832/13 cells, rat islets, and human islets.
- Analyzed protein expression levels.
- Examined subcellular distribution, including nuclear translocation.
Main Results:
- RhoGDIβ expression increased under hyperglycemic stress in all tested models.
- Hyperglycemia induced RhoGDIβ cleavage and nuclear translocation.
- RhoGDIα was found in the nuclear compartment, but its association was unaffected by hyperglycemia.
Conclusions:
- The RhoGDIβ-Rac1 signaling module is implicated in beta-cell dysfunction under metabolic stress.
- RhoGDIβ plays a key role in mediating stress signals from the cytoplasm to the nucleus.
- Targeting this pathway may offer therapeutic strategies for diabetes.
More Related Videos
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
9.3K
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
1.4K
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
01:16Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
01:23Dipeptidyl Peptidase 4 Inhibitors
187
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
187
01:15Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
01:05Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
01:19Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29